Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Pancreatic Cancer × penpulimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Lymphoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumor 1 Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 2 toripalimab 1 penpulimab 1 fluzoparib 1 conteltinib 1 Paclitaxel 1 Nivolumab 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06821503 2026-03-10

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1/2 Recruiting

Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡